购物车
全部删除
您的购物车当前为空
别名 STF083010
STF-083010 是一种 IRE1α 核酸内切酶的选择性抑制剂。


为众多的药物研发团队赋能,
让新药发现更简单!
STF-083010 是一种 IRE1α 核酸内切酶的选择性抑制剂。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 198 | 现货 | |
| 5 mg | ¥ 455 | 现货 | |
| 10 mg | ¥ 622 | 现货 | |
| 25 mg | ¥ 1,050 | 现货 | |
| 50 mg | ¥ 1,870 | 现货 | |
| 100 mg | ¥ 2,980 | 现货 | |
| 200 mg | ¥ 4,530 | 现货 | |
| 500 mg | ¥ 6,830 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 490 | 现货 |
STF-083010 相关产品
| 产品描述 | STF-083010 is a selective inhibitor of the IRE1α endonuclease. |
| 体外活性 | 在化学研究中,WaC3细胞经STF-083010处理后显示出逐渐下降的生长率。在MEC1和MEC2细胞中,STF-083010在48小时培养中产生20%的生长抑制。在MM.1R MM、MM.1S及RPMI 8226细胞系中,STF-083010以剂量和时间依赖的方式展现了细胞静止和细胞毒性活性。在Eμ-TCL1 CLL细胞中,经过3天的培养,STF-083010显示出约70%的生长抑制。在SU8686、Panc0403和MiaPaCa2细胞系中,STF-083010阻断IRE1α的内切酶活性,并抑制XBP1剪接活性,而不影响其激酶活性。 |
| 体内活性 | STF-083010(i.p.,30 mg/kg)在人类多发性骨髓瘤(MM)异种移植模型中显著抑制了肿瘤的生长。 |
| 激酶实验 | Autophosphorylation activity is measured by adding of 32P-γ ATP. Endonuclease activity is measured by the adding of radiolabeled HAC1 508-nt RNA substrate synthesized in vitro using α32P-UTP. Mix STF083010 with recombinant hIRE1 protein, radiolabeled HAC1 508 nt RNA, and appropriate buffers to incubate. Kinase activity is quantitated by polyacrylamide gel electrophoresis. RNAsecleavage products are quantitated by 32P-γATP or 32P-UTP autoradiography. |
| 细胞实验 | 3×10E3 (Panc0403, Panc1005, BxPc3, and MiaPaCa2) cell lines are seeded in 96-well plates overnight, and STF-083010(~50 μM) treatment for 48 hours started the next day. |
| 动物实验 | NOD/SCID/IL2Rγ null mice were injected intraperitoneally of STF-083010(30 mg/kg) dissolved in 16% chremophor. |
| 别名 | STF083010 |
| 分子量 | 317.38 |
| 分子式 | C15H11NO3S2 |
| CAS No. | 307543-71-1 |
| Smiles | O=C1C=Cc2ccccc2\C1=C\NS(=O)(=O)c1cccs1 |
| 密度 | 1.40 g/cm3 (Predicted) |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 40 mg/mL (126.03 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2.5 mg/mL (7.88 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容